AGEPATTERN Precision Health Report · Pre-NCD Prevention · 12 months
Sample · Fictional casePre-NCD Prevention Report
A client not yet diagnosed with a chronic disease but showing several warning signs at once — blood sugar in the prediabetes range, fatty liver, blood pressure beginning to rise, abnormal blood lipids, and a family history of heart disease.
- Report recipient
- Mr. W. (sample case) · Male 46 yrs
- Program period
- Sep 2025 – Sep 2026
- Reviewing physician
- Bunlue Kongchai, M.D. (Reg. 12694)
- Full report
- 24 pages · 5 follow-ups (M0–M12)
Metabolic syndrome
5/5 → 0/5
No longer meets any criterion — without medication
Biological age (PhenoAge)
37.0 yrs
9.0 yrs younger than actual age
Items still to monitor
2 items
LDL cholesterol · Weight
Biological AgePhenoAge vs. Chronological Age
37.0yrs
Younger than chronological age by 9.0 yrs
PhenoAge is calculated from 9 blood markers (Levine 2018) as a research-grade index for tracking trends — not a disease diagnosis. It does not include LDL cholesterol, blood pressure, or body weight.
TrendsBiomarker Graphs M0 → M12
% · target < 5.7
mg/dL · target < 150
mmHg · target < 130
dB/m · target < 248
mg/L · target < 1
mg/dL · target < 100
Still above target — physician to continue assessing
Red dot = baseline · Green dot = follow-up · Dashed line = reference range or target — the report shows both values that met target and those that did not
ResultsSample Table (Selected Items)
| Indicator | M12 Result | Reference Range | Baseline | Status |
|---|---|---|---|---|
| Fasting glucose (FPG) | 94 mg/dL | 70–99 | 112 | Normal |
| Insulin resistance index (HOMA-IR) | 1.7 | < 2.0 | 4.2 | Normal |
| LDL cholesterol (LDL-C) | 118 mg/dL | < 100 (your target) | 162 | Consult physician |
| Lipoprotein(a) (Lp(a)) | 142 nmol/L | < 75 | 145 | Consult physician |
| Liver enzyme (ALT) | 27 U/L | < 40 | 62 | Normal |
| Sleep apnea index (AHI (on CPAP)) | 3.1 events/hr | < 5 | 18 | Normal |
Physician SummaryKey Observations
- Moved out of the prediabetes range without medication (HbA1c 6.1 → 5.6%), and fatty liver has almost returned to normal
- Sleep testing found moderate sleep apnea — referred to a sleep medicine physician from month 2
- LDL fell substantially but remains above target because of genetically high Lp(a) together with a family history — the physician will decide on medication together with the client at the next round
MatchingRisk map by condition (selected)
| Type 2 diabetes | HbA1c 6.1 → 5.6% · HOMA-IR 4.2 → 1.7 | ✓ Out of prediabetes |
|---|---|---|
| High blood pressure | 136/88 → 122/78 mmHg | ✓ Normal |
| Fatty liver (MASLD) | CAP 305 → 236 dB/m · ALT 62 → 27 | ✓ Reversed |
| Cardiovascular disease | LDL 162 → 118 · Lp(a) 142 stable · CAC 0 | ! LDL still needs control |
Full Report 24 pages
Includes physician recommendations (exercise, nutrition, sleep, precautions), results across all dimensions, a physician-approved personalized supplement regimen, glossary, and next-year follow-up plan — provided exclusively to program participants.
Sample document (DEMO) — The recipient is a fictional case. All values are generated to demonstrate the report format. · Non-SaMD: This report is for health management and self-monitoring, not a medical device. It is not intended to diagnose, prevent, treat, or cure any disease. All medical decisions rest with the attending physician. · Supplements are not medicines. · Reviewed by Bunlue Kongchai, M.D. (Reg. 12694) · Report No. BRM-2026-DEMO-NCD · Issued 29 Sep 2026